NXEN (Nexien BioPharma) Accounts Payable: $0.08 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nexien BioPharma Accounts Payable?

Nexien BioPharma NXEN Accounts Payable is $0.08 Mil as of Mar. 2025.

Nexien BioPharma's Accounts Payable for the quarter that ended in Mar. 2025 was $0.08 Mil.

Nexien BioPharma's quarterly Accounts Payable increased from Sep. 2024 ($0.07 Mil) to Dec. 2024 ($0.07 Mil) and increased from Dec. 2024 ($0.07 Mil) to Mar. 2025 ($0.08 Mil).

Nexien BioPharma's annual Accounts Payable increased from Jun. 2022 ($0.02 Mil) to Jun. 2023 ($0.02 Mil) and increased from Jun. 2023 ($0.02 Mil) to Jun. 2024 ($0.05 Mil).

Nexien BioPharma Accounts Payable Related Terms

Nexien BioPharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Nexien BioPharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexien BioPharma Accounts Payable Chart

Nexien BioPharma Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Accounts Payable
Get a 7-Day Free Trial 0.02 0.01 0.02 0.02 0.05

Nexien BioPharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.05 0.07 0.07 0.08

Nexien BioPharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.08 Mil mean?
Nexien BioPharma (NXEN) has a Accounts Payable of $0.08 Mil as of Mar. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Nexien BioPharma and its competitors.
Is Nexien BioPharma's Accounts Payable too high?
Nexien BioPharma's current Accounts Payable is $0.08 Mil.
How does Nexien BioPharma's Accounts Payable compare to FLHLF and ZTS?
Nexien BioPharma's Accounts Payable of $0.08 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Nexien BioPharma and its competitors. Nexien BioPharma's current Accounts Payable is $0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexien BioPharma stock overvalued right now?
Nexien BioPharma (NXEN) has a current Accounts Payable of $0.08 Mil. The current Accounts Payable is $0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Nexien BioPharma (NXEN), the current Accounts Payable is $0.08 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexien BioPharma Business Description

Address 4340 East Kentucky Avenue, Suite 206, Glendale, CO, USA, 80246
Nexien BioPharma Inc is engaged in pre-clinical and drug development activities, by U.S. Food and Drug Administration (FDA) protocols, for certain pharmaceutical formulations that include cannabinoids. The company is pursuing the formulation and development of drugs containing cannabinoids for the treatment of various diseases, disorders, and medical conditions.